Next-generation sequencing identifies thousands of cancer patients who cannot receive immunotherapy
Brigham researchers’ next-generation sequencing findings suggest that updating current cancer treatment guidelines could allow approximately 6,000 more patients in the United States to benefit from immunotherapy treatment each year. suggests Immunotherapy is a highly effective treatment for patients whose cancer has mismatch repair defects, and new research identifies more cancer patients who could benefit from […]
Patients with metastatic colorectal cancer may continue to benefit from immunotherapy even after treatment is discontinued
Credit: Pixabay/CC0 Public Domain The majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with immune checkpoint inhibitors (ICIs) had no disease progression for two years after stopping treatment, a new study reports. There is. Research is published in a diary cancer research communication. ICIs have proven effective against […]
Patients with metastatic colorectal cancer may continue to benefit from immunotherapy even after treatment is discontinued
Credit: Pixabay/CC0 Public Domain The majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with immune checkpoint inhibitors (ICIs) had no disease progression for two years after stopping treatment, a new study reports. There is. Research is published in a diary cancer research communication. ICIs have proven effective against […]